Novavax Announces Pricing of $65 Million Public Offering of Co...
- Written by LATEST ASIANET NEWS RELEASES
- Published in Asia Net
GAITHERSBURG, Md., Dec. 16, 2022 /PRNewswire-AsiaNet/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, today announced the pricing of an underwritten public offering to sell 6,500,000 shares of ...
Authors: LATEST ASIANET NEWS RELEASES